Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”

Makoto Shiragami; Akiko Mizukami; Oscar Leeuwenkamp; Tomas Mrkvan; Emmanuelle Delgleize; Yuichi Kurono; Satoshi Iwata

doi:10.1007/s40121-015-0062-1

Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”

Makoto Shiragami, Akiko Mizukami, Oscar Leeuwenkamp, Tomas Mrkvan, Emmanuelle Delgleize, Yuichi Kurono, Satoshi Iwata

感染症学

研究成果: Letter › 査読

2 被引用数 (Scopus)

本文言語	English
ページ（範囲）	235-244
ページ数	10
ジャーナル	Infectious Diseases and Therapy
巻	4
号	2
DOI	https://doi.org/10.1007/s40121-015-0062-1
出版ステータス	Published - 2015 6月 19

ASJC Scopus subject areas

微生物学（医療）
感染症

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1007/s40121-015-0062-1

他のファイルとリンク

引用スタイル

Shiragami, M., Mizukami, A., Leeuwenkamp, O., Mrkvan, T., Delgleize, E., Kurono, Y., & Iwata, S. (2015). Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”. Infectious Diseases and Therapy, 4(2), 235-244. https://doi.org/10.1007/s40121-015-0062-1

Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”. / Shiragami, Makoto; Mizukami, Akiko; Leeuwenkamp, Oscar その他.
In: Infectious Diseases and Therapy, Vol. 4, No. 2, 19.06.2015, p. 235-244.

研究成果: Letter › 査読

Shiragami, M, Mizukami, A, Leeuwenkamp, O, Mrkvan, T, Delgleize, E, Kurono, Y & Iwata, S 2015, 'Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”', Infectious Diseases and Therapy, vol. 4, no. 2, pp. 235-244. https://doi.org/10.1007/s40121-015-0062-1

Shiragami M, Mizukami A, Leeuwenkamp O, Mrkvan T, Delgleize E, Kurono Y その他. Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”. Infectious Diseases and Therapy. 2015 6月 19;4(2):235-244. doi: 10.1007/s40121-015-0062-1

@article{ac91aeb65767451ab1ecae4d66ecf615,

title = "Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”",

author = "Makoto Shiragami and Akiko Mizukami and Oscar Leeuwenkamp and Tomas Mrkvan and Emmanuelle Delgleize and Yuichi Kurono and Satoshi Iwata",

year = "2015",

month = jun,

day = "19",

doi = "10.1007/s40121-015-0062-1",

language = "English",

volume = "4",

pages = "235--244",

journal = "Infectious Diseases and Therapy",

issn = "2193-8229",

publisher = "Springer Healthcare",

number = "2",

}

TY - JOUR

T1 - Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”

AU - Shiragami, Makoto

AU - Mizukami, Akiko

AU - Leeuwenkamp, Oscar

AU - Mrkvan, Tomas

AU - Delgleize, Emmanuelle

AU - Kurono, Yuichi

AU - Iwata, Satoshi

PY - 2015/6/19

Y1 - 2015/6/19

UR - http://www.scopus.com/inward/record.url?scp=84977106592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977106592&partnerID=8YFLogxK

U2 - 10.1007/s40121-015-0062-1

DO - 10.1007/s40121-015-0062-1

M3 - Letter

AN - SCOPUS:84977106592

SN - 2193-8229

VL - 4

SP - 235

EP - 244

JO - Infectious Diseases and Therapy

JF - Infectious Diseases and Therapy

IS - 2

ER -